The NY Times spreads the panic. I wrote about this recently. Dr. Centor and Dr. RW chime in.
Bottom-line: this is a rare complication mostly found in IV bisphosphonates used to treat cancer. The benefits of Fosamax and other oral bisphosphonates continue to outweigh this rare risk.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
